Dear patients, please know this as you go through your treatment journey: the dedicated technical staff, PhD students, and postdoctoral fellows in Dr. Alana Welm's lab continue to work hard every day (and night!) to bring new hope to breast cancer through innovative research, always with patients in mind.
"breast cancer" News
Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Adam Cohen, MD, MS, was recently honored with a Huntsman Translational Scholar award. He is a researcher and physician, specializing in neuro-oncology and breast oncology.
“Delivering Discoveries: Expanding the Reach of Precision Medicine,” was the theme of the American Society of Clinical Oncology (ASCO) 2018 annual meeting held June 1-5, 2018 in Chicago. One of the largest scientific conferences in the world, the meeting brings together nearly 40,000 attendees and features thousands of studies about new ways to prevent, detect, and treat cancer.
It is patients like you, your loved ones, and Dr. Gertz's parents who keep us motivated and excited to find ways to help in the fight against this terrible disease. We appreciate everything you do as patients—like donating samples and participating in clinical trials—and we want you to know that we are doing everything we can to help patients with breast and uterine cancer.
Alvin Kwok, MD, MPH, is a breast reconstruction surgeon who returned to Utah to join the Huntsman Cancer Institute team. He shares with us how breast reconstruction can help patients' outlook on their cancer journey. We also find out what delicious activities he's up to on his days off.
Huntsman Cancer Institute celebrates International Women's Day 2018 in a conversation with Dr. Theresa Werner. Her patients juggle treatment with lives that often include work, a relationship, and motherhood. She talks with us about the optimistic women she treats in clinic and a stylish first lady of the United States she would trade lives with for a day.
Targeted therapy in cancer treatment is often called personalized or precision medicine, according to the National Institutes of Health. Targeted therapies are designed to be more effective and less harmful than other approaches because the drugs are specially designed to meet the individual characteristics of each patient.
All cancer treatments and medications that are used today were, at one point, part of a clinical trial. Clinical trials can offer hope, particularly in complex diseases such as cancer. But getting access to them can be difficult, especially if patients have to travel a long distance to a hospital that offers trials
Huntsman Cancer Institute (HCI) is pleased to announce the appointment of two of our colleagues as holders of prestigious endowed chairs at the University of Utah. Endowed chairs recognize academic distinction, promote excellence, and provide funds for cutting-edge research.
A conversation with Anna Beck, MD—director of Supportive Oncology and Survivorship at Huntsman Cancer Institute—on a love for medicine that spans three generations and her four-legged family.
After Emma Houston learned she had breast cancer, the first thing she did was go shopping to buy red three-inch high heels. The shoes became as much a hallmark of her cancer journey as her humor and positive outlook.
Support groups and special retreats are helpful for many people with cancer. Merica Hale found a healing place to relax and meet women diagnosed with breast cancer who could offer each other support.
Breast cancer is one of the types of cancer women can be screened for. Talk with your doctor about the cancer screenings that are right for you based on your age, family medical history, and personal medical history.
You might not see us during your visit to Huntsman Cancer Institute (HCI), but we want to let you know that we are working hard in the Varley Lab in the HCI research building next door. We conduct research that improves the treatment and care of patients like you. We are a small group of dedicated young men and women who are developing new strategies to diagnose and treat breast and ovarian cancer.
Mary Chamberlain had completed treatment for one type of cancer, melanoma, when she was diagnosed with breast cancer. She talks about her journey with both cancers, including how she got through chemotherapy when she thought her body couldn’t take it anymore.